Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Pulmonary Disease, Chro...

 

 
 
Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 20/07/2012, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 20/07/2012, Revision: 18, Status: Authorised



 
 
ECDC statement on the Delta variant in EU/EEA | #COVID19



 
 
Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Hemophilia A, Date of authorisation: 08/01/2018, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Hemophilia A, Date of authorisation: 08/01/2018, Revision: 4, Status: Authorised


Actueel zorgnieuws in jouw mailbox ontvangen?
Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.